Low dose methotrexate decreases intraarticular prostaglandin and interleukin 1 levels in antigen induced arthritis in rabbits

Journal of Rheumatology

Volumn 23, Issue 12, 1996, Pages 2092-2097

  Novaes, Gilberto S ^a   Mello, Suzana B V ^a   Laurindo, Ieda M M ^a   Cossermelli, Wilson ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

antiinflammatory agents; eicosanoids; experimental arthritis; interleukin 1; methotrexate

Indexed keywords

DEXAMETHASONE; INDOMETACIN; INTERLEUKIN 1; LEUKOTRIENE B4; METHOTREXATE; PROSTAGLANDIN E2; THROMBOXANE B2;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; RABBIT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CAPILLARY PERMEABILITY; CELL MOVEMENT; DEXAMETHASONE; EICOSANOIDS; INDOMETHACIN; INTERLEUKIN-1; JOINTS; LEUKOCYTE COUNT; LEUKOCYTES; METHOTREXATE; NEUTROPHILS; PROSTAGLANDINS; RABBITS; SODIUM CHLORIDE; SYNOVIAL FLUID; SYNOVIAL MEMBRANE;

EID: 0030470876     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Dumonde DC, Glynn LE: The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol 1962;43:373-83.
2. De Shazo CM, Henson PM, Cochrane CG: Immunologic arthritis in rabbits. J Clin Invest 1972;51:50-6.
3. Arendt WP, Dayer J-M: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
4. Firestein GS, Alvaro-Garcia JM, Maki R: Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol 1990;144:3347-53.
5. Nouri AM, Panayi GS, Goodman SM: Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
6. Miyasaka N, Sato K, Goto M, et al: Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients: Possible involvement in joint destruction. Arthritis Rheum 1988;31:480-6.
7. Wood DD, Ihrie EJ, Dinarello CA, et al: Isolation of an interleukin-1 like factor from human joint effusion. Arthritis Rheum 1983;26:915-93.
8. Eastgate JA, Symons JA, Wood NC, et al: Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 1988;2:706-9.
9. Khale P, Saal JG, Schaudt K, et al: Determination of cytokines in synovial fluids: Correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992;51:731-4.
10. Shore A. Jaglal S, Keystone EC: Enhanced interleukin-1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 1986;65:293-302.
11. Henderson B, Rowe FM, Bird CR, et al: Production of interleukin-1 in the joint during the development of antigen-induced arthritis in the rabbit. Clin Exp Immunol 1988;74:371-6.
12. Maier JAM, HIa T, Maciag T: Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J Biol Chem 1990;265:10805-8.
13. Knott I, Dieu M, Burton M, et al: Induction of cyclooxygenase by interleukin-1: Comparative study between human synovial cells and chondrocytes. J Rheumatol 1994;21:462-6.
14. Szczepanski A, Moatter T, Carey WW, et al: Induction of cyclooxygenase II in human synovial microvessel endothelial cells by interleukin-1. Inhibition by glucocorticoids. Arthritis Rheum 1994;4:495-503.
15. Crofford LJ, Wilder RL. Ristimäki AP, et al: Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-101.
16. Knudsen PJ, Dinarello CA, Strom TB: Prostaglandins posttranscriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cyclic adenosine monophosphate. J Immunol 1986;137:3189-94.
17. Kunkel SL, Chensue SW, Phan SH: Prostaglandins as endogenous mediators of interleukin-1 production. J Immunol 1986;136:186-92.
18. Weinblat ME, Coblyn JS, Fox DA, et al: Efficacy of low dose methotrexate in rheumatoid arthritis. N Engl J Med 1985;312:818-22.
19. Andersen PA, West SG, O'Dell JR, et al: Weekly pulse methotrexate in rheumatoid arthritis. Ann Intern Med 1985;103:489-96.
20. Williams HJ, Wilkens RF, Samuelson CO Jr, et al: Comparison of low dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled trial. Arthritis Rheum 1985;28:721-9.
21. Cronstein BN, Eberle MA, Gruber HE, et al: Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells. Proc Natl Acad Sci USA 1991;88:241-5.
22. Thomas R, Carroll JG: Reduction of leukocyte and interleukin-1β concentration in the synovial fluid of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 1993;36:1244-52.
23. Salmon JA: A radioimmunoassay for 6-keto-prostaglandin Flα. Prostaglandins 1978;51:387-97.
24. 4. Prostaglandins 1982;24:225-15.
25. de Brum-Fernandes AJ, Cossermelli W, Jancar S: Antigen-induced arthritis in rabbits: A suitable experimental model for the study of arachidonic acid metabolites in articular inflammatory processes. Rev Hosp Clin Fac Med S Paulo 1988;43:142-5.
26. Welles WL, Silkworth J, Oronsky AL, et al: Studies on the effect of low dose methotrexate on rat adjuvant arthritis. J Rheumatol 1985;12:904-6.
27. Connolly KM, Stecher VJ, Danis E, et al: Alteration of interleukin-1 production and acute phase response following medication of adjuvant arthritis rats with cyclosporin-A or methotrexate. Int J Immunopharmacol 1988;10:717-28.
28. Hu SK, Mitcho YL, Oronsky AL, et al: Studies on the effect of methotrexate on macrophage function. J Rheumatol 1988;15:206-9.
29. Johnson WJ, DiMartino MJ, Meunier PC, et al: Methotrexate inhibits macrophage activation as well as vascular and cellular inflammatory events in rat adjuvant induced arthritis. J Rheumatol 1988;15:745-9.
30. Barrera P, Boerbooms AMT, Demacker PNM, et al: Circulating concentration and production of cytokines and soluble receptors in rheumatoid arthritis patients: Effects of a single dose methotrexate. Br J Rheumatol 1994;33:1017-24.
31. Chang DM, Weinblatt ME, Schur P: The effects of methotrexate on interleukin-1 in patients with rheumatoid arthritis. J Rheumatol 1992;19:1678-82.
32. Laurindo IMM, Mello SBV, Cossermelli W: Influence of low doses of methotrexate on superoxide anion production by polymorphonuclear leukocytes from patients with rheumatoid arthritis. J Rheumatol 1995;22:633-8.
33. Leroux JL, Damon M, Chavis C, et al: Effects of a single dose of methotrexate on 5- and 12-lipoxygenase products in patients with rheumatoid arthritis. J Rheumatol 1992;19:863-6.
34. Sperling RI, Coblyn JS, Larkin JK, et al: Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate. Arthritis Rheum 1990;33:1149-55.
35. Hawkes JS, Cleland LG, Proudman SM, et al: The effect of methotrexate on ex viva lipooxygenase metabolism in neutrophils from patients with rheumatoid arthritis. J Rheumatol 1994;21:55-8.
36. Segal R, Mozes E, Yaron M, et al: The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum 1989;32:370-7.
37. Chang DM, Baptiste P, Schur PH: The effect of antirheumatic drugs on interleukin-1 (IL-1) activity and IL-1 and IL-1 inhibitor production by human monocytes. J Rheumatol 1990;17:1148-57.
38. Brody M, Bhm I, Bauer R: Mechanism of action of methotrexate: Experimental evidence that methotrexate blocks the binding of interleukin-1 beta to the interleukin-1 receptor on target cells. Eur J Clin Chem Clin Biochem 1993;31:667-74.
39. Blackham A, Farmer JB, Radziwonik H, et al: The role of prostaglandins in rabbit monoarticular arthritis. Br J Pharmacol 1974;51:33-44.
40. 4 and cyclic AMP in patients with rheumatoid arthritis. Scand J Rheumatol 1990;19:71-5.
41. Rola-Pleszczynski M, Lemaire I: Leukotrienes augmented interleukin-1 production by human monocytes. J Immunol 1985;135:3958-61.
42. Kageyama Y, Koide Y, Miyamoto S, et al: Leukotriene B4-induced interleukin-1β in synovial cells from patients with rheumatoid arthritis. Scand J Rheumatol 1994;23:148-50.
43. Bahl AK, Dale MM, Foreman JC: The effect of nonsteroidal antiinflammatory drugs on the accumulation and release of interleukin-1 like activity by peritoneal macrophages from the mouse. Br J Pharmacol 1994;113:809-14.
44. Thomas E, Leroux JL, Blotman F, et al: Enhancement of leukotriene A4 biosynthesis in neutrophils from patients with rheumatoid arthritis after a single glucocorticoid dose. Biochem Pharmacol 1995;49:243-8.
45. Farsky SHP, Sannomia P, Garcia-Leme J: Secreted glucocorticoids regulate leukocyte-endothelial interaction in inflammation. A direct vital microscopic study. J Leuk Biol 1995;57:379-86.
46. Garcia-Leme J, Wilhelm DL: The effects of adrenalectomy and corticoesterone on vascular permeability response in the skin of the rat. Br J Exp Pathol 1975;56:402-7.
47. Garcia-Leme J, Schapoval EES: Stimulation of the hypothalamopituitary-adrenal axis by compound formed in inflamed tissues. Br J Pharmacol 1975;53:75-82.
48. Moraes FR, Garcia-Leme J: Endogenous corticosteroids and insulin in acute inflammation. Microv Res 1982;23:281-93.
49. Lazarevic MB, Skosey JL, Djordjevic-Denic G, et al: Reduction of cortisol levels after a single intra-articular and intramuscular steroid injection. Am J Med 1995;99:370-3.